159 related articles for article (PubMed ID: 10624546)
1. Interleukin-1 beta production in dysthymia before and after pharmacotherapy.
Anisman H; Ravindran AV; Griffiths J; Merali Z
Biol Psychiatry; 1999 Dec; 46(12):1649-55. PubMed ID: 10624546
[TBL] [Abstract][Full Text] [Related]
2. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
Ravindran AV; Guelfi JD; Lane RM; Cassano GB
J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
[TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality.
Hellerstein DJ; Kocsis JH; Chapman D; Stewart JW; Harrison W
Am J Psychiatry; 2000 Sep; 157(9):1436-44. PubMed ID: 10964860
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes.
Kocsis JH; Zisook S; Davidson J; Shelton R; Yonkers K; Hellerstein DJ; Rosenbaum J; Halbreich U
Am J Psychiatry; 1997 Mar; 154(3):390-5. PubMed ID: 9054788
[TBL] [Abstract][Full Text] [Related]
5. Treatment of dysthymia.
Buni TM
J Fam Pract; 1997 Jun; 44(6):528-9. PubMed ID: 9191617
[No Abstract] [Full Text] [Related]
6. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
Keller MB; Gelenberg AJ; Hirschfeld RM; Rush AJ; Thase ME; Kocsis JH; Markowitz JC; Fawcett JA; Koran LM; Klein DN; Russell JM; Kornstein SG; McCullough JP; Davis SM; Harrison WM
J Clin Psychiatry; 1998 Nov; 59(11):598-607. PubMed ID: 9862606
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in treatment response to sertraline versus imipramine in chronic depression.
Kornstein SG; Schatzberg AF; Thase ME; Yonkers KA; McCullough JP; Keitner GI; Gelenberg AJ; Davis SM; Harrison WM; Keller MB
Am J Psychiatry; 2000 Sep; 157(9):1445-52. PubMed ID: 10964861
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features.
Zaharia MD; Ravindran AV; Griffiths J; Merali Z; Anisman H
J Affect Disord; 2000 Apr; 58(1):1-10. PubMed ID: 10760553
[TBL] [Abstract][Full Text] [Related]
9. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features.
Anisman H; Ravindran AV; Griffiths J; Merali Z
Mol Psychiatry; 1999 Mar; 4(2):182-8. PubMed ID: 10208451
[TBL] [Abstract][Full Text] [Related]
10. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management.
Haykal RF; Akiskal HS
J Clin Psychiatry; 1999 Aug; 60(8):508-18. PubMed ID: 10485632
[TBL] [Abstract][Full Text] [Related]
11. Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder.
Tucker P; Ruwe WD; Masters B; Parker DE; Hossain A; Trautman RP; Wyatt DB
Biol Psychiatry; 2004 Jul; 56(2):121-8. PubMed ID: 15231444
[TBL] [Abstract][Full Text] [Related]
12. A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients.
Markowitz JC; Kocsis JH; Bleiberg KL; Christos PJ; Sacks M
J Affect Disord; 2005 Dec; 89(1-3):167-75. PubMed ID: 16263177
[TBL] [Abstract][Full Text] [Related]
13. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments.
Ravindran AV; Anisman H; Merali Z; Charbonneau Y; Telner J; Bialik RJ; Wiens A; Ellis J; Griffiths J
Am J Psychiatry; 1999 Oct; 156(10):1608-17. PubMed ID: 10518174
[TBL] [Abstract][Full Text] [Related]
14. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial.
Moak DH; Anton RF; Latham PK; Voronin KE; Waid RL; Durazo-Arvizu R
J Clin Psychopharmacol; 2003 Dec; 23(6):553-62. PubMed ID: 14624185
[TBL] [Abstract][Full Text] [Related]
15. Ruminative coping among patients with dysthymia before and after pharmacotherapy.
Kelly O; Matheson K; Ravindran A; Merali Z; Anisman H
Depress Anxiety; 2007; 24(4):233-43. PubMed ID: 17004237
[TBL] [Abstract][Full Text] [Related]
16. Early- versus late-onset dythymic disorder: comparison in out-patients with superimposed major depressive episodes.
Klein DN; Schatzberg AF; McCullough JP; Keller MB; Dowling F; Goodman D; Howland RH; Markowitz JC; Smith C; Miceli R; Harrison WM
J Affect Disord; 1999; 52(1-3):187-96. PubMed ID: 10357032
[TBL] [Abstract][Full Text] [Related]
17. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
[TBL] [Abstract][Full Text] [Related]
18. The undertreatment of dysthymia.
Shelton RC; Davidson J; Yonkers KA; Koran L; Thase ME; Pearlstein T; Halbreich U
J Clin Psychiatry; 1997 Feb; 58(2):59-65. PubMed ID: 9062374
[TBL] [Abstract][Full Text] [Related]
19. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
Thase ME; Fava M; Halbreich U; Kocsis JH; Koran L; Davidson J; Rosenbaum J; Harrison W
Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754
[TBL] [Abstract][Full Text] [Related]
20. Are there differences by gender in response to pharmacotherapy for depression?
Marsland TW; Newton W
J Fam Pract; 2000 Dec; 49(12):1149. PubMed ID: 11132066
[No Abstract] [Full Text] [Related]
[Next] [New Search]
